Supreme Court Upholds the Constitutionality of Life Sentences Without Remission Until Natural Death || Supreme Court: Service Benefits Can't be Refused Due to Missing ACRs Not Attributable to Employees || Supreme Court: Courts May Grant Lesser Relief under Order VII Rule 7 CPC, But Not a Different Claim || Supreme Court Dismisses Lokpal's Plea Against Delhi HC Order Quashing Probe into Defence Secretary || SC Grants Bail to Two UAPA Accused, Citing 12-Year Incarceration and Violation of Article 21 || Madras High Court: Seeking Divorce over Wife's Accidental Hip Injury is Inhumane || Kerala High Court Directs Stronger Audit and Financial Oversight in Guruvayur Devaswom || Madras High Court Directs State and Judiciary to Expedite Rape and POCSO Trials || Karnataka HC Upholds RTO's Power to Cancel Registration Secured by False Documents || Karnataka HC: Bengaluru-Mysuru Corridor Could be Biggest Scam, Farmers Deprived of Land

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :